Clinical Trial: Matched Sibling Allogenic Stem Cell Transplantation With Adoptive Immunotherapy With Regulatory And Conventional T Cells For High Risk Acute Myeloid Leukemia

U.S., April 28 -- ClinicalTrials.gov registry received information related to the study (NCT07552649) titled 'Matched Sibling Allogenic Stem Cell Transplantation With Adoptive Immunotherapy With Regulatory And Conventional T Cells For High Risk Acute Myeloid Leukemia' on April 20.

Brief Summary: The study is a multicentric, interventional study that evaluates the efficacy of allogeneic HLA-matched allo-HSCT consisting of myeloablative conditioning coupled with donor Treg/Tcon adoptive immunotherapy for high-risk AML patients.

Study Start Date: April, 2026

Study Type: INTERVENTIONAL

Condition: AML (Acute Myeloid Leukemia)

Intervention: BIOLOGICAL: HSCT with Treg/Tcon adoptive immunotherapy

Purified CD34+ hematopoietic progenitor cell...